United Community Banks, Inc. and Peach State Bancshares, Inc., The Parent of Peach State Bank & Trust, Announce Merger Agreement

GREENVILLE, S.C., April 21, 2026 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (“United”) and Peach State Bancshares, Inc. (“Peach State”) announced today the execution of a definitive merger agreement (the “Merger Agreement”) pursuant to which United will acquire Peach State, and its wholly-owned subsidiary, Peach State Bank & Trust (“Peach State Bank”), in a stock and cash transaction (the “Merger”).

Peach State Bank is headquartered in Gainesville, Georgia, a fast-growing city in Hall County, located approximately fifty miles northeast of Atlanta. Founded in 2005, Peach State Bank has been built on a foundation of exceptional customer service and community commitment. It is an established and respected franchise with an experienced management team led by President and Chief Executive Officer Ron Quinn. Peach State Bank’s high-touch, personalized approach to customer service is delivered to retail and business customers across two locations in Hall County, with branches in Gainesville and Braselton. As of March 31, 2026, Peach State Bank reported total assets of $788 million, with total loans of $498 million, and total deposits of $713 million.

“We are very pleased to join forces with Peach State to strengthen our presence in Gainesville, which is an outstanding area,” said Lynn Harton, Chairman and Chief Executive Officer of United. “United’s culture and Peach State’s culture fit seamlessly together, where we share a deep commitment to service and a strong presence in the communities we serve. Because we already operate in the Gainesville area, this partnership creates a unique opportunity to learn from one another, combine local knowledge, and deepen our impact. Together, we will build even stronger, service-minded teams focused on improving our communities – one customer at a time.”

Ron Quinn, President and Chief Executive Officer of Peach State Bank, stated, “We have spent many years building a strong team and serving our customers in Hall County. As we considered potential partners to help move us into the next phase of our growth, it became clear that United Community was by far the best strategic fit. Their focus on the needs of the customer, combined with their larger balance sheet and expanded product and service offerings, will ensure that our customers continue to receive best in class service. They are also very focused on creating a great place to work for great people, and I know that there will be a strong culture fit across our two teams. I am excited about our partnership with United, and I believe that the combination of our teams will result in tremendous success for both parties and our customers.”

Under the terms of the Merger Agreement, Peach State shareholders will be entitled to elect to receive either the per share cash consideration of $31.75 or the per share stock consideration of 0.8978 shares of United common stock for each share of Peach State common stock outstanding, subject to proration such that fifty percent of the Peach State shares will receive stock consideration and fifty percent of the shares will receive cash consideration. Additionally, stock options will be cashed out at closing. Based on United’s stock price of $34.15 on April 17, 2026, the aggregate value of the Merger is $100.8 million.

The Merger is expected to be accretive to United’s earnings per share by approximately $0.09 per share in 2027, the first full year of combined operations. Assuming that United repurchases shares on the open market, pursuant to its existing share repurchase program, in an amount sufficient to offset the dilution from the shares issued in the transaction, the Merger is expected to be accretive to United’s earnings per share by approximately $0.12 per share in 2027. Additionally, the estimated transaction returns are consistent with United’s stated acquisition criteria pertaining to tangible book value and targeted internal rates of return. The Merger Agreement was unanimously approved by the boards of directors of United and Peach State. The Merger is expected to be completed in the third quarter of 2026 and is subject to customary conditions, including regulatory approval as well as the approval of Peach State’s shareholders.

Hovde Group, LLC acted as financial advisor to United, and Wachtell, Lipton, Rosen & Katz served as United’s legal advisor. Piper Sandler & Co. served as Peach State’s financial advisor, and Alston & Bird, LLP served as Peach State’s legal advisor.

About United Community Banks, Inc.

United Community Banks, Inc. (NYSE: UCB) is the financial holding company for United Community, a top 100 U.S. financial institution committed to building stronger communities and improving the financial health and well-being of its customers. United Community offers a full range of banking, mortgage, and wealth management services. As of March 31, 2026, United Community Banks, Inc. had $28.2 billion in assets and operated 200 offices across Alabama, Florida, Georgia, North Carolina, South Carolina, and Tennessee. The company also manages a nationally recognized SBA lending franchise and a national equipment finance subsidiary, extending its reach to businesses across the country. United Community is the most awarded bank in the Southeast for Retail Banking Customer Satisfaction by J.D. Power, earning more awards than any other bank in the region, including recognition in 12 of the last 17 years. The company has also been named one of the “Best Banks to Work For” by American Banker for nine consecutive years. In commercial banking, United Community earned multiple 2026 Greenwich Best Bank awards for Small Business Banking. Forbes has consistently named United Community among the World’s Best and America’s Best Banks. Learn more at ucbi.com.

About Peach State Bancshares, Inc.

Peach State Bancshares, Inc. is the holding company for Peach State Bank & Trust. The bank is a full-service bank with two branches located in Hall County, Georgia. Peach State Bank & Trust has been a true community bank serving the needs of the Hall County community for over 20 years. As of March 31, 2026, Peach State Bank & Trust had $788 million in assets and operated offices in Gainesville and Braselton, Georgia. The company has been named to Newsweek Magazine’s 2026 list of America’s Best 500 Regional Banks and was one of only three banks in Georgia to receive the highest 5-Star ranking based on financial strength, customer satisfaction, and community banking performance.

Caution About Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In general, forward-looking statements usually may be identified through use of words such as “may,” “believe,” “expect,” “anticipate,” “intend,” “will,” “should,” “plan,” “estimate,” “predict,” “continue” and “potential” or the negative of these terms or other comparable terminology, and include statements related to the expected timing of the closing of the Merger, the expected benefits of the Merger and the estimated returns and other financial impacts of the Merger to United. Forward-looking statements are not historical facts and represent management’s beliefs, based upon information available at the time the statements are made, with regard to the matters addressed; they are not guarantees of future performance. Actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. Forward-looking statements are subject to numerous assumptions, risks and uncertainties that change over time and could cause actual results or financial condition to differ materially from those expressed in or implied by such statements.

Factors that could cause or contribute to such differences include, but are not limited to (1) the risk that the cost savings and any revenue synergies from the Merger may not be realized or take longer than anticipated to be realized, (2) disruption from the Merger of customer, supplier, employee or other business partner relationships, (3) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement, (4) the failure to obtain the necessary approval by the shareholders of Peach State, (5) the possibility that the costs, fees, expenses and charges related to the Merger may be greater than anticipated, (6) the ability of United to obtain required governmental approvals of the Merger on the anticipated timeframe and without the imposition of adverse conditions, (7) reputational risk and the reaction of each of the companies’ customers, suppliers, employees or other business partners to the Merger, (8) the failure of the closing conditions in the Merger Agreement to be satisfied, or any unexpected delay in closing the Merger, (9) the risks relating to the integration of Peach State’s operations into the operations of United, including the risk that such integration will be materially delayed or will be more costly or difficult than expected, (10) the risk of potential litigation or regulatory action related to the Merger, (11) the risks associated with United’s pursuit of future acquisitions, (12) the risk of expansion into new geographic or product markets, (13) the dilution caused by United’s issuance of additional shares of its common stock in the Merger, and (14) general competitive, economic, political and market conditions. Further information regarding additional factors which could affect the forward-looking statements can be found in the cautionary language included under the headings “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors” in United’s Annual Report on Form 10-K for the year ended December 31, 2025, and other documents subsequently filed by United with the U.S. Securities and Exchange Commission (“SEC”).

Many of these factors are beyond United’s and Peach State’s ability to control or predict. If one or more events related to these or other risks or uncertainties materialize, or if the underlying assumptions prove to be incorrect, actual results may differ materially from the forward-looking statements. Accordingly, shareholders and investors should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date of this communication, and neither United nor Peach State undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. New risks and uncertainties may emerge from time to time, and it is not possible for United or Peach State to predict their occurrence or how they will affect United or Peach State.

United and Peach State qualify all forward-looking statements by these cautionary statements.

Important Information About the Merger and Where to Find It

In connection with the Merger, United will file with the SEC a registration statement on Form S-4 that will include a proxy statement of Peach State to be sent to Peach State’s shareholders seeking their approval of the Merger Agreement. The registration statement also will contain the prospectus of United to register the shares of United common stock to be issued in connection with the Merger. INVESTORS AND SHAREHOLDERS OF PEACH STATE ARE ENCOURAGED TO READ THE REGISTRATION STATEMENT, INCLUDING THE PROXY STATEMENT/PROSPECTUS THAT WILL BE A PART OF THE REGISTRATION STATEMENT WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS FILED BY UNITED WITH THE SEC, INCLUDING ANY AMENDMENTS OR SUPPLEMENTS TO THE REGISTRATION STATEMENT AND THOSE OTHER DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT UNITED, PEACH STATE, AND THE MERGER.

The registration statement and other documents filed with the SEC may be obtained for free at the SEC’s website (www.sec.gov). You will also be able to obtain these documents, free of charge, from United at the “Investor Relations” section of United’s website at www.ucbi.com or from Peach State at Peach State’s website at www.peachstate.bank. Copies of the definitive proxy statement/prospectus will also be made available, free of charge, by contacting United Community Banks, Inc., P.O. Box 398, Blairsville, GA 30514, Attn: Jefferson Harralson, Telephone: (864) 240-6208, or Peach State Bancshares, Inc., 121 E. E. Butler Parkway, Gainesville, Georgia 30501, Attn: Ron Quinn, Telephone: (770) 531-2767.

Participants in the Solicitation

United, Peach State, and certain of their respective directors and executive officers, under the rules of the SEC may be deemed to be participants in the solicitation of proxies from Peach State’s shareholders in favor of the approval of the Merger Agreement. Information about such directors and executive officers of United and their direct or indirect interests, by security holdings or otherwise, can be found under the headings “Director Compensation,” “Director Independence,” “Executive Compensation,” and “Security Ownership” in United’s definitive proxy statement in connection with its 2026 annual meeting of shareholders, as filed with the SEC on April 1, 2026 (available at: https://www.sec.gov/ix?doc=/Archives/edgar/data/0000857855/000110465926038366/tm2520272-3_def14a.htm), and other documents subsequently filed by United with the SEC. To the extent holdings of United common stock by its directors or executive officers have changed since the amounts set forth in United’s definitive proxy statement in connection with its 2026 annual meeting of shareholders, such changes have been or will be reflected in filings with the SEC on Form 3 (Initial Statement of Beneficial Ownership of Securities), Form 4 (Statement of Changes in Beneficial Ownership) or Form 5 (Annual Statement of Beneficial Ownership of Securities) (which are available at EDGAR Search Results https://www.sec.gov/edgar/search/#/category=form-cat2&ciks=0000857855&entityName=UNITED%2520COMMUNITY%2520BANKS%2520INC%2520(UCB%252C%2520UCB-PI)%2520(CIK%25200000857855)). Further information regarding the direct or indirect interests of the directors and executive officers of United, along with information about the directors and executive officers of Peach State and their direct or indirect interests and information regarding the interests of other persons who may be deemed participants in the solicitation, may be obtained by reading the proxy statement/prospectus regarding the Merger when it becomes available. Free copies of this document may be obtained as described above.


For more information:


Jefferson Harralson
Chief Financial Officer
(864) 240-6208
[email protected]



SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.

Third Long-Term Agreement Signed by a PMGC Holdings Subsidiary in 2026, Reflecting Continued Growth in the Company’s Aerospace and Defense Supply Chain Presence

NEWPORT BEACH, Calif., April 21, 2026 (GLOBE NEWSWIRE) — SVM Machining, Inc. (d/b/a Silicon Valley Manufacturing) (“SVM”), an ISO 9001:2015 certified precision CNC machining company and wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced the execution of a Long-Term Agreement (“LTA”) with Turbo-Jet Products Co., Inc. (“Turbo-Jet Products”), a California-based aerospace and defense supplier. This marks the third long-term agreement executed by a PMGC Holdings subsidiary in 2026.

Under the terms of the LTA, SVM will supply mission-critical aerospace and defense components in support of Turbo-Jet Products’ commercial and defense programs. The LTA provides a framework governing all future purchase orders issued during its term.

The LTA includes an initial five-year term, with provisions for annual renewals, supporting a long-term strategic supply relationship between the parties.

Strategic Importance

SVM believes this LTA strengthens its position within the aerospace and defense supply chain and enables it to support programs that may include U.S. government and defense-related contracts, in compliance with applicable Federal Acquisition Regulation (FAR) and Defense Federal Acquisition Regulation Supplement (DFARS) requirements.

SVM is registered under the International Traffic in Arms Regulations (ITAR) as of March 20, 2026, and is actively working toward AS9100 certification, a globally recognized quality standard for aerospace manufacturing. SVM believes achieving AS9100 certification would further strengthen its ability to support regulated defense programs and deliver mission-critical components with the highest levels of quality, traceability, and regulatory adherence.

About SVM Machining, Inc.

SVM Machining, Inc. (d/b/a Silicon Valley Manufacturing) is a California-based ISO 9001:2015 Certified precision CNC machining and manufacturing services company that produces high-quality, engineered components for a diverse set of mission-critical industries, including medical technology, aerospace, semiconductor, biotech & pharmaceutical, and transportation. Known for its technical expertise, quality systems, and ability to deliver complex parts with precision tolerances, SVM supports original equipment manufacturers and advanced technology customers with reliable and responsive production capacity. For more information, please visit https://svmfg.com.

About Turbo-Jet Products Co., Inc.

Since 1948, Tur-Bo Jet Products has been providing custom innovative design, manufacturing, and solutions for the aerospace, military, transportation, and medical industries. Turbo-Jet Products is an AS9100 Rev. D / ISO 9001:2015 certified designer and manufacturer of custom electromagnetic, electromechanical, mechanical, fluid, and pneumatic controls. For more information, please visit https://tbj.aero.

About PMGC Holdings Inc.

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. We are committed to exploring opportunities in multiple sectors to maximize growth and value. For more information, please visit https://www.pmgcholdings.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “believes,” “expects,” “plans,” “potential,” “would” and “future” or similar expressions such as “look forward” are intended to identify forward-looking statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore, you should not rely on any of these forward-looking statements. These and other risks are described more fully in PMGC’s filings with the United States Securities and Exchange Commission (“SEC”), including the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, and its other documents subsequently filed with or furnished to the SEC. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at www.sec.gov. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

IR Contact: [email protected]



Telesat schedules first quarter 2026 earnings conference call for May 5, 2026

OTTAWA, Ontario, April 21, 2026 (GLOBE NEWSWIRE) — Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, has scheduled a conference call on Tuesday, May 5, 2026, at 10:30 a.m. EDT to discuss its financial results for the three month period ended March 31, 2026

Prior to the commencement of the call, Telesat will post a news release containing its financial results on its website (www.telesat.com) under the tab “Investors” and the heading “Investor News.”


Dial-in Instructions:

The toll-free dial-in number for the teleconference is +1-800-715-9871. Callers outside of North America should dial +1-646-307-1963. The access code is 6669954 followed by the number sign (#). Please allow at least 15 minutes prior to the scheduled start time to connect to the teleconference. In the event of technical issues, please dial *0 and advise the conference call operator of the company name (Telesat) and the name of the moderator (James Ratcliffe).


Webcast:

The conference call can also be accessed, as a listen in only, at https://edge.media-server.com/mmc/p/7e5e286e. A replay of the webcast will be archived on Telesat’s website under the tab “Investors”.


Dial-in Audio Replay:

A replay of the teleconference will be available one hour after the end of the call on May 5, 2026 until 11:59 p.m. ET on May 19, 2026. To access the replay, please call +1-800-770-2030. Callers from outside North America should dial +1-609-800-9909. The access code is 6669954 followed by the number sign (#).

About Telesat

Backed by a legacy of engineering excellence, reliability and industry-leading customer service, Telesat (Nasdaq and TSX: TSAT) is one of the largest and most innovative global satellite operators. Telesat works collaboratively with its customers to deliver critical connectivity solutions that tackle the world’s most complex communications challenges, providing powerful advantages that improve their operations and drive profitable growth.

Continuously innovating to meet the connectivity demands of the future, Telesat Lightspeed, the company’s state-of-the-art Low Earth Orbit (LEO) satellite network, has been optimized to meet the rigorous requirements of telecom, government, maritime and aeronautical customers. Telesat Lightspeed will redefine global satellite connectivity with ubiquitous, affordable, high-capacity, secure and resilient links with fibre-like speeds. For updates on Telesat, follow us on LinkedIn, X, or visit www.telesat.com.

Investor Relations Contact:

James Ratcliffe
+1 613 748 8424
[email protected]



Anterix and Public Utility District No. 1 of Benton County Bring Private Wireless to the Pacific Northwest

Agreement to deploy 900 MHz network marks a defining moment for the Public Utility District market

WOODLAND PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) — Anterix (NASDAQ: ATEX), the leader in mission-critical private wireless broadband spectrum for utilities, today announced that it has entered into an agreement with Public Utility District No. 1 of Benton County (“Benton PUD”) of Kennewick, WA, to sell a 10 MHz 900 MHz spectrum license – establishing the first private wireless broadband deployment among publicly owned utilities in the Pacific Northwest.

Benton PUD’s 900 MHz network will be utility-owned, utility-controlled, and purpose-built for the operational demands of its 927-square-mile service territory in Benton County, Washington – serving more than 58,000 customers across the communities of Kennewick, Richland, Prosser, Benton City, and Finley. The network will enable advanced grid automation, field workforce connectivity, enhanced outage detection and restoration, and the resilience required to meet Washington’s Clean Energy Transformation Act obligations head on.

This agreement underscores a broader shift in the utility sector. Public Utility Districts (PUDs), both community-owned and locally accountable, are now joining investor-owned utilities in advancing private wireless adoption. What began as early innovation is quickly becoming standard practice, as utilities across ownership models recognize purpose-built connectivity as a strategic necessity.

“Our agreement with Benton PUD reflects the accelerating adoption of private wireless across the utility sector,” said Anterix President & CEO Scott Lang. “PUDs are among the most mission-driven utilities in the country, directly accountable to the communities they serve. When a PUD invests in private wireless, it’s because the case is undeniable.”

Benton PUD General Manager Rick Dunn said, “We see private wireless broadband as foundational infrastructure for the next generation of the grid. By deploying a 900 MHz private network, we’re strengthening operations, enhancing safety and service, and building a more resilient system for the communities we serve. Through Anterix and its ecosystem, we’re translating this investment into measurable outcomes across our service territory.”

Anterix delivers more than spectrum. The company offers a full private wireless platform that enables utilities like Benton PUD to move from agreement to operational network with speed and confidence. Additional offerings include:

  • TowerX™ – nationwide tower access and site optimization, reducing the time and cost of network buildout
  • CatalyX® – a turnkey connectivity management solution for device provisioning and lifecycle management across private and public networks
  • Anterix Active Ecosystem – a network of more than 150 technology and infrastructure partners purpose-built for utility deployment

Together, these capabilities compress the path from spectrum acquisition to operational connectivity – a critical advantage for PUDs and other utilities building for the first time.

Shareholder Contact 

Natasha Vecchiarelli
Vice President, Investor Relations & Corporate Communications
Anterix 
973-531-4397
[email protected] 

Media Contact

Paul Gaige
Senior Vice President
Burson
504-957-1434
[email protected]

About Anterix

Anterix is transforming how critical infrastructure stays connected. As the market leader in mission-critical private wireless broadband spectrum for the utility sector, Anterix delivers more secure, private 900 MHz licensed spectrum and advanced intelligent infrastructure solutions that enhance efficiency, strengthen resilience, and accelerate digital transformation. Backed by a growing ecosystem of industry-leading partners, Anterix provides the connectivity foundation that powers a more resourceful and resilient future. Learn more at www.anterix.com.

Forward-Looking Statements

Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. Words such as “believes,” “anticipates,” “estimates,” “expects,” “intends,” “aims,” “potential,” “will,” “would,” “could,” “considered,” “likely,” “estimate” and variations of these words and similar future or conditional expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements include, but are not limited to, statements regarding: (i) the timing of payments under the Anterix-Benton PUD agreement, (ii) Anterix’s ability to clear any interference with incumbent users of the 900 MHz broadband spectrum allocation in Benton PUD’s service area on a timely basis; and (iii) Anterix’s ability to qualify for and timely secure broadband licenses in Benton PUD’s service area. Any such forward-looking statements are based on the current expectations of Anterix’s management and are subject to a number of risks and uncertainties that could cause Anterix’s actual future results to differ materially from its management’s current expectations or those implied by the forward-looking statements. These risks and uncertainties include, but are not limited to: (i) Anterix may not be successful in commercializing its spectrum assets to its targeted utility and critical infrastructure customers on a timely basis and on favorable terms; (ii) Anterix may be unable to secure broadband licenses from the FCC on a timely and cost-effective basis; (iii) Anterix has a limited operating history with its current business plan, which makes it difficult to evaluate its prospects and future financial results and its business activities, strategic approaches and plans may not be successful; and (iv) the value of Anterix’s spectrum assets may fluctuate significantly based on supply and demand, as well as technical and regulatory changes. These and other risk factors that may affect Anterix’s future results of operations are identified and described in more detail in Anterix’s most recent filings on Forms 10-K and 10-Q and in other filings that it makes with the SEC from time to time. These documents are available on Anterix’s website at www.anterix.com under the Investor Relations section and on the SEC’s website at www.sec.gov. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Except as required by applicable law, Anterix undertakes no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.



United Community Banks, Inc. Reports First Quarter Earnings

Earnings and Revenue Growth Year-Over-Year Driven by Profitability Improvement and Solid Loan Growth

GREENVILLE, S.C., April 21, 2026 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the first quarter of 2026 of $84.3 million and pre-tax, pre-provision income of $119.2 million. Diluted earnings per share of $0.69 for the quarter represented an increase of $0.11 from the first quarter of 2025 and a decrease of $0.01 from the fourth quarter of 2025.

On an operating basis, United’s diluted earnings per share of $0.70 increased 19% from the year-ago quarter. Strong revenue growth and positive operating leverage drove the year-over-year results.

United’s return on assets was 1.22% on both a GAAP and operating basis in the first quarter of 2026, up from 1.02% and 1.04%, GAAP and operating, respectively, for the first quarter of 2025. Return on common equity was 9.4% and return on tangible common equity on an operating basis was 13.1%. On a pre-tax, pre-provision basis, operating return on assets was 1.73% for the quarter. At quarter-end, tangible common equity to tangible assets was 9.9%, equal to the fourth quarter.

Chairman and CEO Lynn Harton stated, “Our first quarter results mark the start of what we expect to be a great year for United. We continue to improve our earning asset mix by growing loans, funded by maturing investment securities and growth in customer deposits. This shift in earning asset composition and our strategic focus on deposit pricing helped to widen our net interest margin by three basis points in the first quarter. In fact, our net interest margin is up 29 basis points when compared to the first quarter of 2025. We entered the year with a small wholesale funding position, but deposit growth allowed that to be completely repaid by the end of the quarter. We took advantage of our strong capital position and repurchased 1.09 million shares of our common stock at an average price of $33.97 per share during the quarter. All our key performance metrics show significant improvement when compared to the first quarter of 2025. With strong capital and liquidity, we notified holders of our remaining $100 million in subordinated debentures of our intent to redeem those securities in the second quarter.

Harton continued, “I’m very proud of our first quarter financial results and also pleased to report that we were notified in March that United had earned its twelfth JD Power award for outstanding customer satisfaction in the Southeast. That is a tremendous accomplishment by our exceptional team of bankers and a testament to the enduring nature and consistency of our strong corporate culture throughout our organization. Congratulations to our entire team for this great recognition of your focus on customer care.”

Net charge-offs were $10.4 million or 0.22% annualized of average loans, compared with 0.21% for the first quarter of 2025 and 0.34% for the fourth quarter of 2025. Nonperforming assets were 0.35% of total assets, up slightly from 0.33% for the fourth quarter. Provision for credit losses was $10.9 million for the first quarter, down from $15.4 million a year ago and $13.7 million for the fourth quarter. As of March 31, the allowance for credit losses represents 1.15% of loans, down slightly from 1.16% at December 31, 2025, reflecting more optimism in the economic forecast.

United also announced today the execution of a definitive merger agreement to acquire Peach State Bancshares, Inc. Details of the transaction are described in a separate presentation, filed with the SEC on April 21 and available within the Investor Relations section of United’s website.

First Quarter 2026 Financial Highlights:

  • EPS of $0.69 was up $0.11 on a GAAP basis compared to first quarter 2025, and EPS of $0.70 was up $0.11, or 19%, on an operating basis
  • Net income of $84.3 million and pre-tax, pre-provision income of $119.2 million, up $12.9 million and $12.6 million, respectively, from a year ago
  • Total revenue of $276.5 million improved $28.8 million, or 12%, from a year ago
  • Net interest margin of 3.65% increased by 29 basis points from a year ago and 3 basis points from the fourth quarter on a lower cost of funds and improving asset mix
  • Provision for credit losses was $10.9 million, down $4.6 million from a year ago and $2.8 million from the fourth quarter; allowance for credit losses coverage down slightly to 1.15% of total loans; net charge-offs were $10.4 million, or 0.22% of average loans, annualized
  • Noninterest expense was up $5.3 million compared to the fourth quarter on a GAAP basis and up $0.2 million on an operating basis
  • Efficiency ratio of 56.7% on a GAAP basis, or 55.7% on an operating basis, improved from a year ago
  • Strong loan production led to loan growth of $218 million, up 4.5% annualized, from the fourth quarter
  • Mortgage closings of $251 million compared to $187 million in first quarter 2025; mortgage rate locks of $408 million compared to $330 million in first quarter 2025
  • Customer deposits were up $237 million from the fourth quarter
  • Return on assets of 1.22% on both a GAAP and operating basis
  • Return on common equity and return on tangible common equity on an operating basis were 9.4% and 13.1%, respectively
  • Maintained strong capital ratios with preliminary Common Equity Tier 1 of 13.4%
  • Quarterly common dividend of $0.25 per share declared during the quarter, up 4% year-over-year
  • Repurchased 1.09 million shares of common stock in the first quarter at an average price of $33.97 per share

Conference Call

United will hold a conference call on Tuesday, April 21, 2026 at 9:00 a.m. EST to discuss the contents of this press release and to share business highlights for the quarter. Participants can pre-register for the conference call by navigating to https://dpregister.com/sreg/10207568/103998c8460. Those without internet access or unable to pre-register may dial in by calling 1-844-676-1337. The conference call also will be webcast and can be accessed by selecting “Events and Presentations” under “News and Events” within the Investor Relations section of the company’s website, ucbi.com

UNITED COMMUNITY BANKS, INC.
Selected Financial Information

(in thousands, except per share data)

      2026       2025     First Quarter

2026 – 2025

Change
    First

Quarter
  Fourth

Quarter
  Third

Quarter
  Second

Quarter
  First

Quarter
 
INCOME SUMMARY                        
Interest revenue   $ 333,961     $ 346,367     $ 353,850     $ 347,365     $ 335,357      
Interest expense     101,197       108,441       120,221       121,834       123,336      
Net interest revenue     232,764       237,926       233,629       225,531       212,021     10 %
Noninterest income     43,746       40,462       43,219       34,708       35,656     23  
Total revenue     276,510       278,388       276,848       260,239       247,677     12  
Provision for credit losses     10,853       13,662       7,907       11,818       15,419     (30 )
Noninterest expense     157,302       152,048       150,868       147,919       141,099     11  
Income before income tax expense     108,355       112,678       118,073       100,502       91,159     19  
Income tax expense     24,066       26,223       26,579       21,769       19,746     22  
Net income     84,289       86,455       91,494       78,733       71,413     18  
Non-operating items     508       606       3,468       4,833       1,297      
Income tax benefit of non-operating items     (113 )     (133 )     (751 )     (1,047 )     (281 )    
Net income – operating

(1)
  $ 84,684     $ 86,928     $ 94,211     $ 82,519     $ 72,429     17  
Pre-tax pre-provision income

(5)
  $ 119,208     $ 126,340     $ 125,980     $ 112,320     $ 106,578     12  
PERFORMANCE MEASURES                        
Per common share:                        
Diluted net income – GAAP   $ 0.69     $ 0.70     $ 0.70     $ 0.63     $ 0.58     19  
Diluted net income – operating (1)     0.70       0.71       0.75       0.66       0.59     19  
Cash dividends declared     0.25       0.25       0.25       0.24       0.24     4  
Book value     30.54       30.17       29.44       28.89       28.42     7  
Tangible book value (3)     22.56       22.24       21.59       21.00       20.58     10  
Key performance ratios:                        
Return on common equity – GAAP (2)(4)     9.35 %     9.48 %     9.20 %     8.45 %     7.89 %    
Return on common equity – operating (1)(2)(4)     9.39       9.53       9.83       8.87       8.01      
Return on tangible common equity – operating (1)(2)(3)(4)     13.05       13.31       13.56       12.34       11.21      
Return on assets – GAAP (4)     1.22       1.21       1.29       1.11       1.02      
Return on assets – operating (1)(4)     1.22       1.22       1.33       1.16       1.04      
Return on assets – pre-tax pre-provision, excluding non-operating items (1)(4)(5)     1.73       1.78       1.83       1.66       1.55      
Net interest margin (fully taxable equivalent) (4)     3.65       3.62       3.58       3.50       3.36      
Efficiency ratio – GAAP     56.66       54.40       54.30       56.69       56.74      
Efficiency ratio – operating (1)     55.65       54.19       53.05       54.84       56.22      
Equity to total assets     12.97       12.99       12.78       12.86       12.56      
Tangible common equity to tangible assets (3)     9.92       9.92       9.71       9.45       9.18      
ASSET QUALITY                        
Nonperforming assets (“NPAs”)   $ 98,623     $ 93,498     $ 97,916     $ 83,959     $ 93,290     6  
ACL, loans     208,396       210,429       215,791       216,500       211,974     (2 )
ACL, total     225,996       225,520       228,276       228,045       223,201     1  
Net charge-offs     10,377       16,418       7,676       8,225       9,607     8  
ACL, loans to loans     1.06 %     1.09 %     1.13 %     1.14 %     1.15 %    
ACL, total to loans     1.15       1.16       1.19       1.21       1.21      
Net charge-offs to average loans (4)     0.22       0.34       0.16       0.18       0.21      
NPAs to total assets     0.35       0.33       0.35       0.30       0.33      
AT PERIOD END ($ in millions)                        
Loans   $ 19,602     $ 19,384     $ 19,175     $ 18,921     $ 18,425     6  
Investment securities     5,889       5,988       6,163       6,382       6,661     (12 )
Total assets     28,177       28,003       28,143       28,086       27,874     1  
Deposits     24,025       23,798       24,021       23,963       23,762     1  
Shareholders’ equity     3,655       3,639       3,597       3,613       3,501     4  
Common shares outstanding (thousands)     119,684       120,598       121,553       121,431       119,514      


(1) Excludes non-operating items as detailed on Non-GAAP Performance Measures Reconciliation. (2) Net income less preferred stock dividends, divided by average common equity. (3) Excludes effect of acquisition related intangibles and associated amortization. (4) Annualized. (5) Excludes income tax expense and provision for credit losses.

UNITED COMMUNITY BANKS, INC.
Loan Portfolio Composition at Period-End
      2026       2025     Linked Quarter Change
  Year over Year Change
(in millions)   First Quarter   Fourth Quarter


  Third Quarter


  Second Quarter


  First Quarter


   
LOANS BY CATEGORY                                    
Owner occupied commercial RE   $ 4,041     $ 3,950     $ 3,678     $ 3,563     $ 3,419     $ 91     $ 622  
Income producing commercial RE     4,984       5,032       4,534       4,548       4,416       (48 )     568  
Commercial & industrial     2,771       2,696       2,593       2,516       2,506       75       265  
Commercial construction & land     1,072       998       1,734       1,752       1,681       74       (609 )
Equipment financing     1,897       1,848       1,808       1,778       1,723       49       174  
Total commercial     14,765       14,524       14,347       14,157       13,745       241       1,020  
Residential mortgage     3,122       3,157       3,198       3,210       3,218       (35 )     (96 )
Home equity     1,344       1,319       1,252       1,180       1,099       25       245  
Residential construction & land     185       191       178       174       171       (6 )     14  
Consumer     187       188       192       191       183       (1 )     4  
Other     (1 )     5       8       9       9       (6 )     (10 )
Total loans   $ 19,602     $ 19,384     $ 19,175     $ 18,921     $ 18,425     $ 218     $ 1,177  
                                     
LOANS BY MARKET                                    
Georgia   $ 4,617     $ 4,635     $ 4,584     $ 4,551     $ 4,484     $ (18 )   $ 133  
South Carolina     3,037       2,971       2,926       2,872       2,821       66       216  
North Carolina     2,722       2,712       2,676       2,626       2,666       10       56  
Tennessee     1,895       1,913       1,902       1,881       1,880       (18 )     15  
Florida     3,229       3,102       3,040       2,966       2,572       127       657  
Alabama     1,049       1,050       1,054       1,016       1,009       (1 )     40  
Commercial Banking Solutions     3,053       3,001       2,993       3,009       2,993       52       60  
Total loans   $ 19,602     $ 19,384     $ 19,175     $ 18,921     $ 18,425     $ 218     $ 1,177  

UNITED COMMUNITY BANKS, INC.
Credit Quality
(in thousands)
      2026       2025  
    First

Quarter


  Fourth

Quarter


  Third

Quarter
NONACCRUAL LOANS                  
Owner occupied RE   $ 18,265     $ 11,165     $ 10,275  
Income producing RE     11,037       11,488       10,884  
Commercial & industrial     19,890       18,294       25,754  
Commercial construction & land     17       18       3,198  
Equipment financing     8,024       10,383       9,716  
Total commercial     57,233       51,348       59,827  
Residential mortgage     31,906       32,423       28,978  
Home equity     6,209       5,247       5,234  
Residential construction & land     355       1,079       1,241  
Consumer     1,009       1,001       1,163  
Total nonaccrual loans     96,712       91,098       96,443  
OREO and repossessed assets     1,911       2,400       1,473  
Total NPAs   $ 98,623     $ 93,498     $ 97,916  

      2026       2025  
    First Quarter   Fourth Quarter   Third Quarter
(in thousands)   Net Charge-Offs   Net Charge-Offs to Average Loans

(1)
  Net Charge-Offs   Net Charge-Offs to Average Loans

(1)
  Net Charge-Offs   Net Charge-Offs to Average Loans

(1)
NET CHARGE-OFFS (RECOVERIES) BY CATEGORY                        
Owner occupied RE   $ 666     0.07 %   $ 1,610     0.17 %   $ 2,497     0.28 %
Income producing RE     (85 )   (0.01 )     (116 )   (0.01 )     (106 )   (0.01 )
Commercial & industrial     3,309     0.50       7,557     1.15       (1,132 )   (0.18 )
Commercial construction & land     6           1,484     0.35       491     0.11  
Equipment financing     5,835     1.29       5,092     1.12       5,487     1.23  
Total commercial     9,731     0.27       15,627     0.43       7,237     0.20  
Residential mortgage     133     0.02       126     0.02       (259 )   (0.03 )
Home equity     (54 )   (0.02 )     (94 )   (0.03 )     19     0.01  
Residential construction & land     12     0.03       16     0.03       12     0.03  
Consumer     555     1.21       743     1.55       667     1.39  
Total   $ 10,377     0.22     $ 16,418     0.34     $ 7,676     0.16  
                         

(1) Annualized.
                       

UNITED COMMUNITY BANKS, INC.
Consolidated Balance Sheets

(Unaudited)


(in thousands, except share and per share data)   March 31,

2026
  December 31,
2025
ASSETS        
Cash and due from banks   $ 177,025     $ 202,586  
Interest-bearing deposits in banks     316,116       193,168  
Cash and cash equivalents     493,141       395,754  
Trading securities     103,384        
Debt securities available-for-sale     3,574,546       3,750,863  
Debt securities held-to-maturity (fair value $1,878,414 and $1,918,426, respectively)     2,211,523       2,237,356  
Loans held for sale     41,357       39,381  
Loans and leases held for investment     19,601,641       19,384,317  
Less allowance for credit losses – loans and leases     (208,396 )     (210,429 )
Loans and leases, net     19,393,245       19,173,888  
Premises and equipment, net     391,883       393,714  
Bank-owned life insurance     365,492       364,184  
Goodwill and other intangible assets, net     964,819       967,882  
Other assets     637,192       679,532  
Total assets   $ 28,176,582     $ 28,002,554  
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Liabilities:        
Deposits:        
Noninterest-bearing demand   $ 6,473,101     $ 6,252,252  
NOW and interest-bearing demand     5,900,748       5,969,864  
Money market     6,720,216       6,696,530  
Savings     1,101,590       1,085,331  
Time     3,664,706       3,619,189  
Brokered     164,704       175,264  
Total deposits     24,025,065       23,798,430  
Short-term borrowings           85,000  
Long-term debt     120,500       120,400  
Accrued expense and other liabilities     376,351       360,038  
Total liabilities     24,521,916       24,363,868  
Shareholders’ equity:        
Common stock, $1 par value; 200,000,000 shares authorized, 119,684,031 and 120,598,266 shares issued and outstanding, respectively     119,684       120,598  
Capital surplus     2,721,132       2,754,399  
Retained earnings     968,188       914,261  
Accumulated other comprehensive loss     (154,338 )     (150,572 )
Total shareholders’ equity     3,654,666       3,638,686  
Total liabilities and shareholders’ equity   $ 28,176,582     $ 28,002,554  

UNITED COMMUNITY BANKS, INC.

Consolidated Statements of Income
(Unaudited)
    Three Months Ended

March 31,


(in thousands, except per share data)     2026       2025  
Interest revenue:            
Loans, including fees   $ 286,599     $ 274,056  
Investment securities, including tax exempt of $1,646 and $1,678, respectively     45,344       58,850  
Trading securities     785        
Deposits in banks and short-term investments     1,233       2,451  
Total interest revenue     333,961       335,357  
             
Interest expense:            
Deposits:            
NOW and interest-bearing demand     28,129       37,390  
Money market     40,709       49,541  
Savings     480       624  
Time     28,711       31,379  
Deposits     98,029       118,934  
Short-term borrowings     998       1,107  
Federal Home Loan Bank advances     969       433  
Long-term debt     1,201       2,862  
Total interest expense     101,197       123,336  
Net interest revenue     232,764       212,021  
             
Noninterest income:            
Service charges and fees     9,545       9,535  
Mortgage loan gains and other related fees     8,029       6,122  
Wealth management fees     4,629       4,465  
Net gains from sales of other loans     1,893       1,396  
Lending and loan servicing fees     3,971       4,165  
Securities gains, net     133       6  
Other     15,546       9,967  
Total noninterest income     43,746       35,656  
Total revenue     276,510       247,677  
             
Provision for credit losses     10,853       15,419  
             
Noninterest expense:            
Salaries and employee benefits     101,249       84,267  
Communications and equipment     14,102       13,699  
Occupancy     11,725       10,929  
Advertising and public relations     2,397       1,881  
Postage, printing and supplies     2,757       2,561  
Professional fees     5,576       5,931  
Lending and loan servicing expense     2,582       1,987  
Outside services – electronic banking     3,559       2,763  
FDIC assessments and other regulatory charges     2,269       4,642  
Amortization of intangibles     3,063       3,286  
Merger-related and other charges     873       1,297  
Other     7,150       7,856  
Total noninterest expense     157,302       141,099  
Income before income taxes     108,355       91,159  
Income tax expense     24,066       19,746  
Net income     84,289       71,413  
Preferred stock dividends           1,573  
Earnings allocated to participating securities     552       411  
Net income available to common shareholders   $ 83,737     $ 69,429  
             
Net income per common share:            
Basic   $ 0.69     $ 0.58  
Diluted     0.69       0.58  
Weighted average common shares outstanding:            
Basic     120,498       120,043  
Diluted     120,723       120,201  

UNITED COMMUNITY BANKS, INC.
Average Consolidated Balance Sheets and Net Interest Analysis
For the Three Months Ended March 31,
      2026       2025  

(dollars in thousands, fully taxable equivalent (FTE))
  Average Balance   Interest


  Average Rate   Average Balance   Interest


  Average Rate
Assets:                            
Interest-earning assets:                            
Loans, net of unearned income (FTE) (1)(2)   $ 19,403,795     $ 286,629     5.99 %   $ 18,213,501     $ 273,930     6.10 %
AFS & HTM taxable securities (3)     5,845,672       43,698     2.99       6,737,658       57,172     3.39  
AFS & HTM tax-exempt securities (FTE) (1)(3)     346,420       2,202     2.54       356,712       2,245     2.52  
Other interest-earning assets     389,637       2,540     2.64       400,592       3,001     3.04  
Total interest-earning assets (FTE)     25,985,524       335,069     5.22       25,708,463       336,348     5.29  
                             
Noninterest-earning assets:                            
Allowance for credit losses     (212,867 )               (210,169 )          
Cash and due from banks     200,085                 219,540            
Premises and equipment     393,853                 396,443            
Other assets (3)     1,705,566                 1,610,104            
Total assets   $ 28,072,161               $ 27,724,381            
                             
Liabilities and Shareholders’ Equity:                            
Interest-bearing liabilities:                            
Interest-bearing deposits:                            
NOW and interest-bearing demand   $ 5,853,104       28,129     1.95     $ 6,134,004       37,390     2.47  
Money market     6,826,707       40,709     2.42       6,583,963       49,541     3.05  
Savings     1,089,856       480     0.18       1,096,308       624     0.23  
Time     3,651,034       28,183     3.13       3,446,048       30,831     3.63  
Brokered time deposits     60,279       528     3.55       50,447       548     4.41  
Total interest-bearing deposits     17,480,980       98,029     2.27       17,310,770       118,934     2.79  
Federal funds purchased and other borrowings     107,668       998     3.76       80,760       1,107     5.56  
Federal Home Loan Bank advances     102,278       969     3.84       38,900       433     4.51  
Long-term debt     120,450       1,201     4.04       254,220       2,862     4.57  
Total borrowed funds     330,396       3,168     3.89       373,880       4,402     4.77  
Total interest-bearing liabilities     17,811,376       101,197     2.30       17,684,650       123,336     2.83  
                             
Noninterest-bearing liabilities:                            
Noninterest-bearing deposits     6,265,370                 6,194,217            
Other liabilities     337,611                 369,939            
Total liabilities     24,414,357                 24,248,806            
Shareholders’ equity     3,657,804                 3,475,575            
Total liabilities and shareholders’ equity   $ 28,072,161               $ 27,724,381            
                             
Net interest revenue (FTE)       $ 233,872             $ 213,012      
Net interest-rate spread (FTE)             2.92 %             2.46 %
Net interest margin (FTE) (4)             3.65 %             3.36 %


(1) Interest revenue on tax-exempt securities and loans includes a taxable-equivalent adjustment to reflect comparable interest on taxable securities and loans. The FTE adjustment totaled $1.11 million and $991,000, respectively, for the three months ended March 31, 2026 and 2025. The tax rate used to calculate the adjustment was 25%, reflecting the statutory federal income tax rate and the federal tax adjusted state income tax rate.



(2) Included in the average balance of loans outstanding are loans on which the accrual of interest has been discontinued and loans that are held for sale.



(3) Unrealized gains and losses on AFS securities, including those related to the transfer from AFS to HTM, have been reclassified to other assets. Pretax unrealized losses of $176 million in 2026 and $269 million in 2025 are included in other assets for purposes of this presentation.



(4) Net interest margin is taxable equivalent net interest revenue divided by average interest-earning assets.

UNITED COMMUNITY BANKS, INC.
Non-GAAP Performance Measures Reconciliation
Selected Financial Information

(in thousands, except per share data)

      2026       2025  
    First

Quarter
  Fourth

Quarter
  Third

Quarter
  Second

Quarter
  First

Quarter
Noninterest income reconciliation                    
Noninterest income (GAAP)   $ 43,746     $ 40,462     $ 43,219     $ 34,708     $ 35,656  
Gain on terminated cash flow hedge     (5,184 )                        
Noninterest income – operating   $ 38,562     $ 40,462     $ 43,219     $ 34,708     $ 35,656  
                     
Noninterest expense reconciliation                    
Noninterest expense (GAAP)   $ 157,302     $ 152,048     $ 150,868     $ 147,919     $ 141,099  
Payroll transition bonus     (6,704 )                        
FDIC special assessment accrual reversal     1,885                          
Merger-related and other charges     (873 )     (606 )     (3,468 )     (4,833 )     (1,297 )
Noninterest expense – operating   $ 151,610     $ 151,442     $ 147,400     $ 143,086     $ 139,802  
                     
Net income to operating income reconciliation                    
Net income (GAAP)   $ 84,289     $ 86,455     $ 91,494     $ 78,733     $ 71,413  
Gain on terminated cash flow hedge     (5,184 )                        
Payroll transition bonus     6,704                          
FDIC special assessment accrual reversal     (1,885 )                        
Merger-related and other charges     873       606       3,468       4,833       1,297  
Income tax benefit of non-operating items     (113 )     (133 )     (751 )     (1,047 )     (281 )
Net income – operating   $ 84,684     $ 86,928     $ 94,211     $ 82,519     $ 72,429  
                     
Net income to pre-tax pre-provision income reconciliation                    
Net income (GAAP)   $ 84,289     $ 86,455     $ 91,494     $ 78,733     $ 71,413  
Income tax expense     24,066       26,223       26,579       21,769       19,746  
Provision for credit losses     10,853       13,662       7,907       11,818       15,419  
Pre-tax pre-provision income   $ 119,208     $ 126,340     $ 125,980     $ 112,320     $ 106,578  
                     
Diluted income per common share reconciliation                    
Diluted income per common share (GAAP)   $ 0.69     $ 0.70     $ 0.70     $ 0.63     $ 0.58  
Gain on terminated cash flow hedge     (0.03 )                        
Payroll transition bonus     0.04                          
FDIC special assessment accrual reversal     (0.01 )                        
Merger-related and other charges     0.01       0.01       0.02       0.03       0.01  
Deemed dividend on preferred stock redemption                 0.03              
Diluted income per common share – operating   $ 0.70     $ 0.71     $ 0.75     $ 0.66     $ 0.59  
                     
Book value per common share reconciliation                    
Book value per common share (GAAP)   $ 30.54     $ 30.17     $ 29.44     $ 28.89     $ 28.42  
Effect of goodwill and other intangibles     (7.98 )     (7.93 )     (7.85 )     (7.89 )     (7.84 )
Tangible book value per common share   $ 22.56     $ 22.24     $ 21.59     $ 21.00     $ 20.58  
                     
Return on tangible common equity reconciliation                    
Return on common equity (GAAP)     9.35 %     9.48 %     9.20 %     8.45 %     7.89 %
Gain on terminated cash flow hedge     (0.45 )                        
Payroll transition bonus     0.58                          
FDIC special assessment accrual reversal     (0.16 )                        
Merger-related and other charges     0.07       0.05       0.29       0.42       0.12  
Deemed dividend on preferred stock redemption                 0.34              
Return on common equity – operating     9.39       9.53       9.83       8.87       8.01  
Effect of goodwill and other intangibles     3.66       3.78       3.73       3.47       3.20  
Return on tangible common equity – operating     13.05 %     13.31 %     13.56 %     12.34 %     11.21 %
                     
Return on assets reconciliation                    
Return on assets (GAAP)     1.22 %     1.21 %     1.29 %     1.11 %     1.02 %
Gain on terminated cash flow hedge     (0.06 )                        
Payroll transition bonus     0.07                          
FDIC special assessment accrual reversal     (0.02 )                        
Merger-related and other charges     0.01       0.01       0.04       0.05       0.02  
Return on assets – operating     1.22 %     1.22 %     1.33 %     1.16 %     1.04 %
                     
Return on assets to return on assets – pre-tax pre-provision reconciliation                    
Return on assets (GAAP)     1.22 %     1.21 %     1.29 %     1.11 %     1.02 %
Income tax expense     0.35       0.37       0.38       0.31       0.29  
Provision for credit losses     0.16       0.19       0.11       0.17       0.23  
Gain on terminated cash flow hedge     (0.08 )                        
Payroll transition bonus     0.10                          
FDIC special assessment accrual reversal     (0.03 )                        
Merger-related and other charges     0.01       0.01       0.05       0.07       0.01  
Return on assets – pre-tax pre-provision – operating     1.73 %     1.78 %     1.83 %     1.66 %     1.55 %
                     
Efficiency ratio reconciliation                    
Efficiency ratio (GAAP)     56.66 %     54.40 %     54.30 %     56.69 %     56.74 %
Gain on terminated cash flow hedge     1.03                          
Payroll transition bonus     (2.41 )                        
FDIC special assessment accrual reversal     0.68                          
Merger-related and other charges     (0.31 )     (0.21 )     (1.25 )     (1.85 )     (0.52 )
Efficiency ratio – operating     55.65 %     54.19 %     53.05 %     54.84 %     56.22 %
                     
Tangible common equity to tangible assets reconciliation                    
Equity to total assets (GAAP)     12.97 %     12.99 %     12.78 %     12.86 %     12.56 %
Effect of goodwill and other intangibles     (3.05 )     (3.07 )     (3.07 )     (3.10 )     (3.06 )
Effect of preferred equity                       (0.31 )     (0.32 )
Tangible common equity to tangible assets     9.92 %     9.92 %     9.71 %     9.45 %     9.18 %



About United Community Banks, Inc.


United Community Banks, Inc. (NYSE: UCB) is the financial holding company for United Community, a top-100 U.S. financial institution committed to building stronger communities and improving the financial health and well-being of its customers. United Community offers a full range of banking, mortgage and wealth management services. As of March 31, 2026, United Community Banks, Inc. had $28.2 billion in assets and operated 200 offices across Alabama, Florida, Georgia, North Carolina, South Carolina and Tennessee. The company also manages a nationally recognized SBA lending franchise and an equipment finance subsidiary, extending its reach to businesses across the country. United Community is the most awarded bank in the Southeast for Retail Banking Customer Satisfaction by J.D. Power, earning more awards than any other bank in the region, including recognition in 12 of the last 17 years. The company has also been named one of the “Best Banks to Work For” by American Banker for nine consecutive years. In commercial banking, United Community earned multiple 2026 Greenwich Best Bank awards for Small Business Banking. Forbes has consistently named United Community among the World’s Best and America’s Best Banks. Learn more at ucbi.com.

Non-GAAP Financial Measures

This press release, including the accompanying financial statement tables, contains financial information determined by methods other than in accordance with generally accepted accounting principles, or GAAP. This financial information includes certain operating performance measures, which exclude merger-related and other charges that are not considered part of recurring operations, such as “noninterest income – operating”, “noninterest expense – operating”, “operating net income,” “pre-tax, pre-provision income,” “operating net income per diluted common share,” “operating earnings per share,” “tangible book value per common share,” “operating return on common equity,” “operating return on tangible common equity,” “operating return on assets,” “return on assets – pre-tax, pre-provision – operating,” “return on assets – pre-tax, pre-provision,” “operating efficiency ratio,” and “tangible common equity to tangible assets.” These non-GAAP measures are included because United believes they may provide useful supplemental information for evaluating United’s underlying performance trends. These measures should be viewed in addition to, and not as an alternative to or substitute for, measures determined in accordance with GAAP, and are not necessarily comparable to non-GAAP measures that may be presented by other companies. To the extent applicable, reconciliations of these non-GAAP measures to the most directly comparable measures as reported in accordance with GAAP are included with the accompanying financial statement tables.

Caution About Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In general, forward-looking statements usually may be identified through use of words such as “may,” “believe,” “expect,” “anticipate,” “intend,” “will,” “should,” “plan,” “estimate,” “predict,” “continue” and “potential” or the negative of these terms or other comparable terminology. Forward-looking statements are not historical facts and represent management’s beliefs, based upon information available at the time the statements are made, with regard to the matters addressed; they are not guarantees of future performance. Actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. Forward-looking statements are subject to numerous assumptions, risks and uncertainties that change over time and could cause actual results or financial condition to differ materially from those expressed in or implied by such statements.

Factors that could cause or contribute to such differences include, but are not limited to (1) the risk that the cost savings and any revenue synergies from the merger with Peach State Bancshares, Inc. (the “Merger”) may not be realized or take longer than anticipated to be realized, (2) disruption from the Merger of customer, supplier, employee or other business partner relationships, (3) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement, (4) the failure to obtain the necessary approval by the shareholders of Peach State, (5) the possibility that the costs, fees, expenses and charges related to the Merger may be greater than anticipated, (6) the ability of United to obtain required governmental approvals of the Merger on the anticipated timeframe and without the imposition of adverse conditions, (7) reputational risk and the reaction of each of the companies’ customers, suppliers, employees or other business partners to the Merger, (8) the failure of the closing conditions in the Merger Agreement to be satisfied, or any unexpected delay in closing the Merger, (9) the risks relating to the integration of Peach State’s operations into the operations of United, including the risk that such integration will be materially delayed or will be more costly or difficult than expected, (10) the risk of potential litigation or regulatory action related to the Merger, (11) the risks associated with United’s pursuit of future acquisitions, (12) the risk of expansion into new geographic or product markets, (13) the dilution caused by United’s issuance of additional shares of its common stock in the Merger, and (14) general competitive, economic, political and market conditions. Further information regarding additional factors which could affect the forward-looking statements can be found in the cautionary language included under the headings “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors” in United’s Annual Report on Form 10-K for the year ended December 31, 2025, and other documents subsequently filed by United with the U.S. Securities and Exchange Commission (“SEC”).

Many of these factors are beyond United’s ability to control or predict. If one or more events related to these or other risks or uncertainties materialize, or if the underlying assumptions prove to be incorrect, actual results may differ materially from the forward-looking statements. Accordingly, shareholders and investors should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date of this communication, and United undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. New risks and uncertainties may emerge from time to time, and it is not possible for United to predict their occurrence or how they will affect United.

United qualifies all forward-looking statements by these cautionary statements.


For more information:


Jefferson Harralson
Chief Financial Officer
(864) 240-6208
[email protected]



Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement 

HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announced that it has received notification from The Nasdaq Stock Market LLC (“Nasdaq”) confirming the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

Nasdaq determined that, for the 10 consecutive business days from April 6, 2026 to April 17, 2026, the closing bid price of the Company’s common stock was at or above $1.00 per share. Accordingly, Nasdaq has advised that the matter is now closed.

About Plus Therapeutics 

Headquartered in Houston, Texas, Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes. Combining image-guided local beta radiation and targeted drug delivery approaches, the Company is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). The Company has built a supply chain through strategic partnerships that enable the development, manufacturing and future potential commercialization of its products.

Investor Contact

CORE IR


[email protected]



Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

Two oral presentations including late-breaker at SID 

Data will cover Phase 1 clinical trial of soquelitinib for atopic dermatitis, including new immunologic and biomarker data supporting drug-free remissions

Investor and analyst meeting scheduled for 1:30 pm ET (12:30 pm CT) on May 14, 2026

Company to report first quarter 2026 financial results on May 7, 2026

SOUTH SAN FRANCISCO, Calif., April 21, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, announced today that it will host an in-person and virtual investor and analyst meeting on May 14, 2026 to highlight soquelitinib data being presented at the Society for Investigative Dermatology (SID) Annual Meeting, which is taking place May 13-16, 2026 in Chicago. The meeting will be hosted by Richard A. Miller, M.D., co-founder, president and chief executive officer of Corvus, and will feature guest speakers who will discuss the soquelitinib Phase 1 clinical trial data, including new immunologic and biomarker data, that focus on the drug’s mechanism of action and potential for drug-free remissions. The guest speakers are:

  • Albert S. Chiou, M.D., MBA, Clinical Professor, Dermatology and Director of Clinical Research in the Department of Dermatology at Stanford University Medical Center
  • Kavita Sarin, M.D., Ph.D., Professor of Dermatology and Director of the Stanford Skin Cancer Genetics Program at the Stanford Cancer Institute

The meeting will take place from 1:30 – 2:30 pm ET (12:30 – 1:30 pm CT) and will be available via live webcast (including presentation slides) via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website.

Society for Investigative Dermatology Annual Meeting Presentations

Final data from the randomized, blinded, placebo-controlled Phase 1 trial evaluating soquelitinib in patients with moderate-to-severe atopic dermatitis will be presented in two oral sessions at the SID meeting. The presentation details are as follows:


Oral Presentation


Title: Immunologic and clinical activity of soquelitinib, a selective ITK inhibitor, in atopic dermatitis
Abstract #: 0483
Date / Time: May 14, 2026, 8:45 – 8:55 am CT
Presenter: Kavita Sarin, M.D., Ph.D.


Late-Breaking Oral Presentation


Title: Soquelitinib, an ITK inhibitor, Produces Prolonged Drug-Free Remissions in Atopic Dermatitis
Abstract #: LB1154
Date / Time: May 16, 2026,10:40 – 10:50 am CT
Presenter: Albert Chiou, M.D.

First Quarter 2026 Financial Results

The Company plans to provide a business update and report first quarter 2026 financial results in a press release on May 7, 2026. Given the investor and analyst meeting on May 14, this quarter the Company will not host a conference call and webcast in conjunction with the announcement of its first quarter 2026 results.

About Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of immune diseases and cancer. The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Soquelitinib is being evaluated in a registration Phase 3 clinical trial for relapsed/refractory PTCL and in a Phase 2 clinical trial for the treatment of atopic dermatitis. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com or follow the Company on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements, including statements related to soquelitinib Phase 1 clinical trial data, including new immunologic and biomarker data supporting drug-free remissions, and related presentations; the timing of the Company’s press release regarding the first quarter 2026 financial results and business update; and the potential of ITK inhibition as a new approach to immunotherapy to treat a broad range of immune diseases and cancer. All statements other than statements of historical fact contained in this press release are forward-looking statements. These statements often include words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may” or similar expressions. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission on March 12, 2026, as well as other documents that may be filed by the Company from time to time with the Securities and Exchange Commission. In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the Company’s ability to demonstrate sufficient evidence of efficacy and safety in its clinical trials of its product candidates; the accuracy of the Company’s estimates relating to its ability to initiate and/or complete preclinical studies and clinical trials and release data from such studies and clinical trials; the results of preclinical studies and interim data from clinical trials not being predictive of future results; the Company’s ability to enroll sufficient numbers of patients in its clinical trials; the unpredictability of the regulatory process; regulatory developments in the United States and foreign countries; the costs of clinical trials may exceed expectations; the Company’s ability to accurately estimate the cash on hand providing funding into the second quarter of 2028 and the Company’s ability to raise additional capital. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the events and circumstances reflected in the forward-looking statements will be achieved or occur, and the timing of events and circumstances and actual results could differ materially from those projected in the forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. The Company’s results for the fourth quarter and year ended December 31, 2025 are not necessarily indicative of its operating results for any future periods.

INVESTOR CONTACT:

Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
[email protected]

MEDIA CONTACT:

Julia Stern
Real Chemistry
+1-763-350-5223
[email protected]



BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models


  • Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line models

  • Immune cells activated by Bria-OTS+ exhibit serial killing activity across multiple rounds of tumor cell challenge

PHILADELPHIA and VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is presenting positive data from its preclinical Bria-OTS+ platform at the 2026 American Association for Cancer Research (AACR) Annual Meeting taking place April 17–22 at the San Diego Convention Center in San Diego, California.

The poster is summarized below and linked here: https://briacell.com/scientific-publications/.

Title:
Re-Engineering Cancer Vaccines: Bria-OTS+ Integrates Innate and Adaptive Immunity for Broad and Persistent Anti-Tumor Responses

Session Category: Clinical Research
Session Title: Vaccines and Other Immunomodulatory Agents
Session: 4/21/2026 2:00-5:00 PM
Location: Poster Section 49
Poster Board Number: 12
Poster Number: 6701

Summary: Bria-OTS+ is a personalized, off-the-shelf, next-generation genetically engineered whole-cell cancer immunotherapy platform designed to enhance efficacy and safety. Our results demonstrate that Bria-OTS+ activates key components of both the innate and adaptive immune systems to broadly target and destroy cancer cells across solid tumors. These effects include coordinated activation of CD4⁺ and CD8⁺ T cells, NK cells, NKT cells, dendritic cells, and B cells, together with increased cytokine release and sustained immune competence without exhaustion—helping address an important mechanism of cancer progression.

Data presented includes the following:

  • Rapid activation of innate and adaptive immune responses: Bria-BRES+ (breast cancer) and Bria-PROS+ (prostate cancer) drove early activation and proliferation of key immune cells including CD4+ and CD8+ T cells, NK cells, and NKT cells, enhanced cytotoxic activity against parental tumor targets, and increased CD80/CD86 expression on dendritic and B cells, consistent with improved antigen-presentation.
  • Sustained, long-lasting and targeted anti-tumor activity: Bria-BRES+ and Bria-PROS+ generated durable cytokine responses and maintained cytotoxic, serial killing activity through repeated cancer cell challenges without evidence of functional exhaustion. Bria-OTS+ also showed limited induction of immunosuppressive cell populations including regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs).
  • Broad tumor recognition may reduce escape risk: Bria-BRES+ and Bria-PROS+ cells demonstrated anti-tumor activity against multiple tumor targets, supporting the potential of Bria-OTS+ to drive broad, cross-tumor immune responses, reduce immune escape, and limit cancer progression.
  • Bria-OTS+ proposed mechanism of action: Following intradermal administration, Bria-OTS+ is designed to activate T cells and NK cells directly, while professional antigen-presenting cells (APCs) take up tumor specific antigens, migrate to regional lymph nodes and prime tumor-specific T cells to drive a systemic anti-tumor immune response.

Miguel A. Lopez-Lago, PhD, BriaCell’s Chief Scientific Officer, commented, “We are thrilled with our data showing early, strong, and long-lasting anti-cancer activity of Bria-OTS+ in multiple cancer models, boosting the immune system response, and potentially overcoming common cancer cell resistance mechanisms. Our findings strongly support targeted anti-cancer effects of Bria-OTS+ and warrant additional testing of the Bria-OTS+ platform in clinical settings.”

“Based on these promising preclinical findings, we are advancing Bria-OTS+ with the goal of entering the clinic for our first indications of metastatic breast cancer and prostate cancer later this year, with additional indications (lung cancer and melanoma) planned for 2027,” added Dr. William V. Williams, BriaCell’s President and CEO.

About BriaCell Therapeutics Corp.

BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.

Safe Harbor

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements, including those about: BriaCell presenting positive data from its preclinical Bria-OTS+ platform at the AACR , and BriaCell’s expectations that the Bria-OTS+ platform will enable the delivery of powerful and long-lasting immune activity against cancer; whether additional immune activating factors will enhance efficacy of the Bria-OTS+ platform; whether prior results will be replicated in clinical studies of the next generation Bria-BRES+ breast cancer and Bria-PROS+ prostate cancer programs utilizing the Bria‑OTS+ platform; and expectations for what will be investigated in BriaCell’s planned Phase 1/2a clinical studies of Bria-OTS+; are based on BriaCell’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading “Risks and Uncertainties” in the Company’s most recent Management’s Discussion and Analysis, under the heading “Risk Factors” in the Company’s most recent Annual Information Form, and under “Risks and Uncertainties” in the Company’s other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under the Company’s profiles on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

Company Contact:

William V. Williams, MD
President & CEO
1-888-485-6340
[email protected] 

Investor Relations Contact:

[email protected]



Serve Robotics to Report First Quarter 2026 Financial Results, Host Conference Call and Webcast on May 7

SAN FRANCISCO, April 21, 2026 (GLOBE NEWSWIRE) — Serve Robotics Inc. (“Serve”) (Nasdaq: SERV), a leading autonomous robotics company, today announced that it will report its 2026 first quarter financial results Thursday, May 7, 2026 after market close. 

Conference Call and Webcast Information

Company management will host a conference call at 2 p.m. PT / 5 p.m. ET on May 7, 2026 to review the 2026 first quarter financial results. A live audio webcast will be available at investors.serverobotics.com and a replay will be available at the same location.

Analysts and investors who wish to submit questions to management may send an email to [email protected] by close of business on Tuesday, May 5, 2026.

If you wish to receive company email notifications, please register at https://investors.serverobotics.com/ir-resources/email-alerts

About Serve Robotics

Serve Robotics (Nasdaq: SERV) designs and operates autonomous robots that navigate and operate in complex, human-centric environments. Since spinning off from Uber in 2021, Serve has deployed more than 2,000 robots across the U.S., reaching a population of approximately 3 million and supporting delivery for more than 4,500+ restaurants. In 2026, Serve acquired Diligent Robotics, expanding its operations beyond sidewalk delivery into indoor service robots used in hospitals. Serve designs both the hardware and software behind its robots, enabling them to operate safely in public and private environments at scale.

For more information, visit www.serverobotics.com or follow Serve on X, Instagram, and LinkedIn @serverobotics.

Contacts

Media
[email protected]

Investor Relations
[email protected]



PHINIA to Participate in Oppenheimer’s 21st Annual Industrial Growth Conference

PHINIA to Participate in Oppenheimer’s 21st Annual Industrial Growth Conference

AUBURN HILLS, Mich.–(BUSINESS WIRE)–
PHINIA Inc. (NYSE: PHIN), a leader in premium fuel systems, electrical systems and aftermarket solutions, announced today that it will participate in Oppenheimer’s 21st Annual Industrial Growth Conference on Tuesday, May 5, 2026. Conference participation will be virtual and include a Q&A session to discuss dynamics across the various markets PHINIA serves around the world and the Company’s business.

PHINIA’s President and CEO, Brady Ericson, and Senior VP and ​CFO, Chris Gropp, will participate in the Q&A session with Patrick Schuchard, equity research associate at Oppenheimer. Event information can be found below.

Event Title: Oppenheimer 21st Annual Industrial Growth Conference

Event Date: Tuesday, May 5, 2026, 10:30 AM Eastern Time (9:30 AM Central Time)

Live Webcast Info:https://event.summitcast.com/view/RyxiUgLVMCDv2W8fW3DqdG/QyEagzraRiGiYSuUDNCjQC

About PHINIA

PHINIA is an independent, market-leading, premium solutions and components provider with over 100 years of manufacturing expertise and industry relationships, with a strong brand portfolio that includes DELPHI®, DELCO REMY® and HARTRIDGETM. With approximately 12,500 employees and over 40 locations in 20 countries, PHINIA is headquartered in Auburn Hills, Michigan, USA.

Across commercial vehicles and industrial applications (medium-duty and heavy-duty trucks, buses and other off-highway construction, marine, agricultural and aerospace and defense), light commercial vehicles (vans and trucks) and light passenger vehicles (passenger cars, mini-vans, cross-overs and sport-utility vehicles), we develop fuel systems, electrical systems and aftermarket solutions designed to keep combustion engines operating at peak performance, while at the same time investing in advanced technologies to unlock the potential of alternative fuels.

By providing what the market needs today to become more efficient and sustainable, while also developing innovative products and solutions to contribute to lower carbon mobility, we are the partner of choice for a diverse array of customers – powering our shared journey toward a cleaner tomorrow.

© 2026 PHINIA Inc. All Rights Reserved.

(DELCO REMY is a registered trademark of General Motors LLC, licensed to PHINIA Technologies Inc.)

Cautionary Statement Regarding Forward-Looking Statements

This event may contain forward-looking statements within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical fact that provide current expectations or forecasts of future events based on certain assumptions and are not guarantees of future performance. Forward-looking statements use words such as “anticipate,” “believe,” “continue,” “could,” “designed,” “effect,” “estimate,” “evaluate,” “expect,” “forecast,” “goal,” “initiative,” “intend,” “likely,” “may,” “outlook,” “plan,” “potential,” “predict,” “project,” “pursue,” “seek,” “should,” “target,” “when,” “will,” “would,” and other words of similar meaning.

Forward-looking statements are subject to risks, uncertainties, and factors relating to our business and operations, all of which are difficult to predict and which could cause our actual results to differ materially from the expectations expressed in or implied by such forward-looking statements. Risks, uncertainties, and factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: adverse changes in general business and economic conditions, including recessions, adverse market conditions or downturns and other factors, including geopolitical tensions and related trade restrictions, impacting the global transportation and industrial equipment industries; our inability to deliver new products, services and technologies in response to changing consumer preferences and evolving exhaust emissions regulations, or acceleration of the market for electric vehicles or deceleration of the market for alternative fuel technologies, including for use in internal combustion engines; competitive industry conditions; failure to identify, consummate, effectively integrate or realize the expected benefits from acquisitions, partnerships or other strategic investments; failure of or disruption in our technology infrastructure, including a disruption related to cybersecurity; pricing pressures from customers; elevated inflation rates and volatility in the costs of commodities used in the production of our products; difficulties launching new machine, engine or vehicle programs; changes in U.S. and foreign administrative policy, including increases in tariffs, changes to existing trade agreements and import or export licensing requirements and exchange controls, and any resulting changes in international trade relations; our inability to identify, attract, retain and develop a qualified global workforce; our inability to protect our intellectual property; failure to achieve the anticipated savings and benefits from restructuring and other actions, including those intended to improve future profitability and competitiveness, optimize our product portfolio and operations and execute our strategy; extraordinary events, including natural disasters or extreme weather events, political disruptions, terrorist attacks, pandemics or other public health crises, and acts of war; risks related to our international operations; economic, geopolitical, social and market conditions impacting our business in China; supply chain disruptions, including due to U.S. and foreign government action; our reliance on a limited number of OEM customers; work stoppages, production shutdowns and similar events or conditions; liabilities related to product warranties, litigation and other claims; current and future environmental, health and safety, human rights and other laws and regulations related to corporate sustainability; tax audits or similar processes, and changes in tax laws or tax rates taken by taxing authorities; governmental investigations and related proceedings; the impacts of climate change, regulations related to climate change, various stakeholders’ emphasis on reducing the impacts of climate change and other related matters; compliance with and changes in other laws and regulations impacting our operations; impairment charges on goodwill, indefinite-lived intangible assets and long-lived assets; changes in interest rates and asset returns that increase our pension funding obligations; restrictive covenants and other requirements impacting our financial and operating flexibility pursuant to the agreements governing our indebtedness; risks relating to the Spin-Off, including a determination that the Spin-Off does not qualify as tax-free for U.S. federal income tax purposes, our or our Former Parent’s failure to perform under, or additional disputes that may arise between the parties relating to, various transaction agreements executed in connection with the Spin-Off and any amendments and restatements thereto, and the availability of, and our ability to use, various credits and offsets detailed in such agreements or the settlement agreement between the Company and our Former Parent; and other risks and uncertainties described in Item 1A, “Risk Factors” and in our other reports filed from time to time with the Securities and Exchange Commission (the SEC).

We caution attendees not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

IR contact:

Kellen Ferris

Vice President of Investor Relations

[email protected]

+1 947-262-5256

Media contact:

Kevin Price

Global Brand & Communications Director

[email protected]

+44 (0) 7795 463871

Category: IR

KEYWORDS: Michigan United States North America

INDUSTRY KEYWORDS: General Automotive Engineering Automotive Manufacturing Other Energy Utilities Manufacturing Aftermarket Other Transport Automotive Trucking Alternative Energy Rail Energy Transport

MEDIA:

Logo
Logo